Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
adesso SE

Start price
Target price
Perf. (%)
€194.40
23.12.21
-
23.12.22
-33.95%
25.08.22

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€61.45
23.12.21
-
23.12.22
8.62%
25.08.22

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€61.45
23.12.21
-
23.12.22
8.62%
25.08.22

buy
PNE AG

Start price
Target price
Perf. (%)
€8.38
23.12.21
-
23.12.22
102.63%
25.08.22

buy
Hornbach Holding AG & Co. KGaA

Start price
Target price
Perf. (%)
€129.10
23.12.21
-
23.12.22
-43.57%
25.08.22

buy
GFT Technologies AG

Start price
Target price
Perf. (%)
€43.35
23.12.21
-
23.12.22
-18.69%
25.08.22

buy
Energiekontor

Start price
Target price
Perf. (%)
€69.70
23.12.21
-
23.12.22
35.01%
25.08.22

buy
ATOSS Software AG

Start price
Target price
Perf. (%)
€203.50
23.12.21
-
23.12.22
-31.30%
25.08.22

buy
Nordex SE

Start price
Target price
Perf. (%)
€14.14
23.12.21
-
23.12.22
-11.10%
25.01.22

buy
Nordex SE

Start price
Target price
Perf. (%)
€14.14
23.12.21
-
23.12.22
-11.10%
25.01.22

buy
Amyris Biotechnology Inc.

Start price
Target price
Perf. (%)
€5.00
23.12.21
-
23.12.22
-22.05%
13.09.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
buy
Cytomx Therapeutics Inc

Start price
Target price
Perf. (%)
€3.49
21.12.21
-
21.12.22
7.56%
25.12.21

Risky Investment
buy
Nordex SE

Start price
Target price
Perf. (%)
€13.52
20.12.21
€20.00
20.12.22
-27.09%
08.09.22

Could be worthwhile Investment >10% per year
buy
Nordex SE

Start price
Target price
Perf. (%)
€13.52
20.12.21
€20.00
20.12.22
-27.09%
08.09.22

Could be worthwhile Investment >10% per year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€6.41
20.12.21
€7.20
20.12.22
-15.91%
30.01.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€26.94
20.12.21
€18.00
20.12.22
-0.33%
14.03.22

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€29.15
20.12.21
-
20.12.22
-12.35%
10.01.22

Top 10 in its market
Some uniques
Could be worthwhile Investment >10% per year
buy
Kontron AG

Start price
Target price
Perf. (%)
€14.59
17.12.21
-
17.12.22
5.41%
18.12.22

buy
Kontron AG

Start price
Target price
Perf. (%)
€14.59
17.12.21
-
17.12.22
5.41%
18.12.22

buy
Novavax Inc.

Start price
Target price
Perf. (%)
€183.96
17.12.21
€240.00
17.12.22
-37.46%
10.01.22

Could be worthwhile Investment >10% per year
Some uniques
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€32.60
16.12.21
-
16.12.22
38.19%
25.12.21

Could be worthwhile Investment >10% per year
buy
Kontron AG

Start price
Target price
Perf. (%)
€14.30
16.12.21
-
16.12.22
11.61%
27.12.21

Could be worthwhile Investment >10% per year
buy
Kontron AG

Start price
Target price
Perf. (%)
€14.30
16.12.21
-
16.12.22
11.61%
27.12.21

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€24.64
16.12.21
€33.00
31.12.23
-67.02%
07.09.22

Could be very worthwhile Investment >20% year
buy
Nordex SE

Start price
Target price
Perf. (%)
€14.03
15.12.21
€16.00
15.12.22
2.92%
13.01.22

Risky Investment